chr1-181490624-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.266+6614G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0739 in 145,774 control chromosomes in the GnomAD database, including 729 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.074 ( 729 hom., cov: 30)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.761

Publications

1 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.266+6614G>T intron_variant Intron 1 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.266+6614G>T intron_variant Intron 1 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.266+6614G>T intron_variant Intron 1 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.266+6614G>T intron_variant Intron 1 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.266+6614G>T intron_variant Intron 1 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.701+6614G>T intron_variant Intron 3 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.0736
AC:
10716
AN:
145670
Hom.:
721
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.175
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0812
Gnomad ASJ
AF:
0.0137
Gnomad EAS
AF:
0.136
Gnomad SAS
AF:
0.0376
Gnomad FIN
AF:
0.00512
Gnomad MID
AF:
0.0426
Gnomad NFE
AF:
0.0233
Gnomad OTH
AF:
0.0594
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0739
AC:
10768
AN:
145774
Hom.:
729
Cov.:
30
AF XY:
0.0734
AC XY:
5164
AN XY:
70384
show subpopulations
African (AFR)
AF:
0.176
AC:
6985
AN:
39694
American (AMR)
AF:
0.0814
AC:
1151
AN:
14140
Ashkenazi Jewish (ASJ)
AF:
0.0137
AC:
47
AN:
3428
East Asian (EAS)
AF:
0.137
AC:
677
AN:
4948
South Asian (SAS)
AF:
0.0381
AC:
172
AN:
4512
European-Finnish (FIN)
AF:
0.00512
AC:
46
AN:
8990
Middle Eastern (MID)
AF:
0.0489
AC:
13
AN:
266
European-Non Finnish (NFE)
AF:
0.0233
AC:
1558
AN:
66880
Other (OTH)
AF:
0.0587
AC:
118
AN:
2010
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
450
900
1350
1800
2250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0358
Hom.:
415
Bravo
AF:
0.0826
Asia WGS
AF:
0.0820
AC:
284
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.0050
DANN
Benign
0.69
PhyloP100
-0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12060765; hg19: chr1-181459760; API